EXCELLENT (Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing) Registry.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 01 Aug 2013
At a glance
- Drugs Everolimus; Sirolimus
- Indications Coronary artery disease; Coronary artery restenosis; Myocardial ischaemia
- Focus Therapeutic Use
- Acronyms EXCELLENT-REGISTRY
- 28 Jun 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 27 Aug 2009 New trial record